快速診斷市場規模、佔有率、成長分析，按產品、按來源、按技術、按分銷管道、按最終用途、按地區 - 行業預測，2025 年至 2032 年

2023 年全球快速診斷市場規模價值 364 億美元，預計將從 2024 年的 441.2 億美元成長到 2032 年的 2054.1 億美元，預測期內（2025-2032 年）的複合年成長率為 21.2%。

全球感染疾病和慢性病的迅速增加以及對精準診斷的需求不斷成長，預計將推動快速診斷市場大幅成長。對創新診斷技術研究的持續投入為產業供應商創造了新的機會。照護現場和家庭檢測解決方案的日益普及進一步推動了這一勢頭。此外，政府積極採取措施提高早期診斷意識並改善快速診斷技術，預計將在 2031 年之前增加快速診斷公司的收益。然而，先進診斷產品的高成本、熟練專業人員的短缺、嚴格的法規環境和供應鏈問題等挑戰可能會阻礙整個研究期間及以後的廣泛採用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

快速診斷市場規模（按產品分類）

• 市場概況
• 傳染病檢查
  • 呼吸道傳染病檢查產品
  • 流感
  • 肝炎
  • HIV
  • 其他傳染病檢查
• 血糖監測
• 心臟代謝檢測
• 血液凝固檢驗產品
• 妊娠和生育能力測試
• 腫瘤/癌症標記檢測產品
• 尿液檢查產品
• 膽固醇檢測產品
• 血液檢測產品
• 藥物濫用 (DOA) 檢測產品
• 大便潛血試驗產品
• 其他產品

快速診斷市場規模（按購買目的地分類）

• 市場概況
• 在商店
• 處方箋測試

按技術分類的快速診斷市場規模

• 市場概況
• 流通式
• 固相
• 橫向流動
• 聚集測定
• 其他技術

按分銷管道分類的快速診斷市場規模

• 市場概況
• 醫院藥房
• 店鋪
• 電子商務
• 其他分銷管道

快速診斷市場規模（按最終用途分類）

• 市場概況
• 診斷中心
• 居家護理
• 醫院藥房
• 其他最終用戶

快速診斷市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Danaher（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Thermo Fisher Scientific（USA）
• BD（Becton, Dickinson and Company）（USA）
• QuidelOrtho（USA）
• Bio-Rad Laboratories（USA）
• Hologic（USA）
• Cepheid（USA）
• Ortho Clinical Diagnostics（USA）
• Siemens Healthineers（Germany）
• Sysmex（Japan）
• Fujifilm Holdings（Japan）
• DiaSorin（Italy）
• BioMerieux（France）
• Instrumentation Laboratory（USA）

結論和建議

Global Rapid Diagnostics Market size was valued at USD 36.4 billion in 2023 and is poised to grow from USD 44.12 billion in 2024 to USD 205.41 billion by 2032, growing at a CAGR of 21.2% during the forecast period (2025-2032).

The global surge in infectious and chronic diseases, coupled with an increasing demand for precision diagnostics, is poised to drive significant growth in the rapid diagnostics market. Continued investment in researching innovative diagnostic technologies will create new opportunities for industry providers. The rising popularity of point-of-care and home-based testing solutions further supports this momentum. Additionally, proactive government initiatives aimed at enhancing awareness of early diagnosis and improving rapid diagnostic technologies are anticipated to bolster revenue for rapid diagnostics companies through 2031. However, challenges such as the high costs associated with advanced diagnostic products, a shortage of skilled professionals, stringent regulatory environments, and supply chain issues may hinder widespread adoption throughout the study period and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Diagnostics Market Segments Analysis

Global Rapid Diagnostics Market is segmented by Product, Purchase, Technology, Distribution Channel, End Use and region. Based on Product, the market is segmented into Infectious Disease Testing, Glucose Monitoring, Cardiometabolic Testing, Coagulation Testing Products, Pregnancy And Fertility Testing, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Fecal Occult Testing Products and Other Products. Based on Purchase, the market is segmented into OTC and Prescription-Based Tests. Based on Technology, the market is segmented into Flow-Through, Solid Phase, Lateral Flow, Agglutination Assays and Other Technologies. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Brick & Mortar, E-Commerce and Other Distribution Channels. Based on End Use, the market is segmented into Diagnostic Centers, Homecare Settings, Hospital Pharmacies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market is experiencing significant growth driven by the rising prevalence of infectious diseases worldwide. As these diseases become more widespread, there is an increasing demand for effective diagnostic solutions. Rapid testing enables timely detection of infections, allowing for prompt interventions that can prevent the escalation of outbreaks into potential pandemics. This heightened awareness of infectious diseases and the importance of accurate diagnostics is further propelling the demand for rapid diagnostic tools. Consequently, the need for advanced diagnostic procedures is pivotal in addressing health crises and ensuring public safety on a global scale.

Restraints in the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market faces significant constraints due to stringent regulations imposed by authorities and governments, necessitating comprehensive documentation and testing. These rigorous compliance requirements create challenges for companies in the sector, often leading to delays in obtaining necessary approvals for their products. This intricate approval process can hinder innovation and slow the overall growth trajectory of the rapid diagnostics market, potentially affecting its future outlook and limiting timely access to critical diagnostic tools. Consequently, the complex regulatory environment poses a substantial barrier to the advancement and widespread adoption of rapid diagnostics technologies.

Market Trends of the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market is witnessing a significant trend towards the integration of artificial intelligence (AI) technologies, enhancing accuracy and efficiency in diagnostic processes. Companies are increasingly harnessing AI for predictive analytics, enabling early disease detection and improved patient outcomes. This shift is driven by the rapid digitization of healthcare, which facilitates real-time data analysis and personalized medicine approaches. As AI continues to evolve, it will create new opportunities in the rapid diagnostics sector, ultimately optimizing healthcare workflows and fostering innovation. This trend is expected to shape the landscape of diagnostics, paving the way for smarter, faster, and more reliable healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Rapid Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Infectious Disease Testing
  • Respiratory Infection Testing Products
  • Influenza
  • Hepatitis
  • HIV
  • Other Infectious Disease Tests
• Glucose Monitoring
• Cardiometabolic Testing
• Coagulation Testing Products
• Pregnancy And Fertility Testing
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drug-Of-Abuse (DOA) Testing Products
• Fecal Occult Testing Products
• Other Products

Global Rapid Diagnostics Market Size by Purchase & CAGR (2025-2032)

• Market Overview
• OTC
• Prescription-Based Tests

Global Rapid Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Flow-Through
• Solid Phase
• Lateral Flow
• Agglutination Assays
• Other Technologies

Global Rapid Diagnostics Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Brick & Mortar
• E-Commerce
• Other Distribution Channels

Global Rapid Diagnostics Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Diagnostic Centers
• Homecare Settings
• Hospital Pharmacies
• Other End Users

Global Rapid Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Purchase, Technology, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Product, Purchase, Technology, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Purchase, Technology, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Purchase, Technology, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Purchase, Technology, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations